Page last updated: 2024-08-21

alpha-aminopyridine and Asthma, Exercise-Induced

alpha-aminopyridine has been researched along with Asthma, Exercise-Induced in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bethke, T; Birraux, G; Hatzelmann, A; Leclerc, V; Neuhäuser, M; Timmer, W; Wurst, W	1

Trials

1 trial(s) available for alpha-aminopyridine and Asthma, Exercise-Induced

Article	Year
The new phosphodiesterase 4 inhibitor roflumilast is efficacious in exercise-induced asthma and leads to suppression of LPS-stimulated TNF-alpha ex vivo. Journal of clinical pharmacology, 2002, Volume: 42, Issue:3 Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adult; Aminopyridines; Analysis of Variance; Asthma, Exercise-Induced; Benzamides; Confidence Intervals; Cross-Over Studies; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclopropanes; Double-Blind Method; Humans; Lipopolysaccharides; Male; Phosphodiesterase Inhibitors; Tumor Necrosis Factor-alpha	2002

Article

Year

The new phosphodiesterase 4 inhibitor roflumilast is efficacious in exercise-induced asthma and leads to suppression of LPS-stimulated TNF-alpha ex vivo.

Journal of clinical pharmacology, 2002, Volume: 42, Issue:3

Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adult; Aminopyridines; Analysis of Variance; Asthma, Exercise-Induced; Benzamides; Confidence Intervals; Cross-Over Studies; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclopropanes; Double-Blind Method; Humans; Lipopolysaccharides; Male; Phosphodiesterase Inhibitors; Tumor Necrosis Factor-alpha

2002